Universitaetsspital Basel

6 trials 5 recruiting Academic / non-commercial

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

5 Recruiting

0 Completed trials

9 Countries active

9 Unique IMPs

N/A Results reported

Phase III

Phase II

Phase IV

Phase III: 1 Phase II: 4 Phase IV: 1

Oversight events:

1 corrective measure across 1 trial

View oversight register →

Top IMPs

N-TEC 2 ACETYLSALICYLIC ACID 1 APIXABAN 1 CLOPIDOGREL 1 DABIGATRAN ETEXILATE 1 EDOXABAN 1 EMPAGLIFLOZIN 1 LACTOSE MONOHYDRATE 1

All trials

6 total

MidregiOnal proatrial natriuretic peptide to guide SEcondary Stroke prevention: The MOSES-study Pending

2024-517600-11-01 Phase III 2 countries ACETYLSALICYLIC ACID; APIXABAN; CLOPIDOGREL; DABIGATRAN ETEXILATE; EDOXABAN
the EMPOWER Study Recruiting

2023-508610-42-00 Phase II 2 countries EMPAGLIFLOZIN; LACTOSE MONOHYDRATE
Treatment of osteoarthritis behind the kneecap with tissue engineered nasal cartilage in a randomized, controlled, multicenter clinical tria… Recruiting

2023-508640-21-00 Phase II 2 countries N-TEC
Impact of beta blocker administration on aortic valve replacement Recruiting

2024-518731-11-00 Phase IV 2 countries
Randomized, controlled, multi-center clinical trial for the treatment of osteoarthritis behind the kneecap with tissue engineered nasal cart… Recruiting

2024-513683-25-00 Phase II 7 countries N-TEC
The OxyTUTION Trial Recruiting

2024-516813-19-00 Phase II 2 countries

Showing 1–6 of 6 trials

← All sponsors A–Z